Eaton Vance Management’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-958
Closed -$26K 2382
2021
Q4
$26K Sell
958
-724
-43% -$21K ﹤0.01% 2328
2021
Q3
$0 Sell
1,682
-233
-12% -$7.74K ﹤0.01% 2446
2021
Q2
$59K Buy
1,915
+1,334
+230% +$38.5K ﹤0.01% 2102
2021
Q1
$18K Buy
+581
New +$16.5K ﹤0.01% 2130
2016
Q4
Sell
-10,000
Closed -$206K 1012
2016
Q3
$206K Hold
10,000
﹤0.01% 954
2016
Q2
$306K Sell
10,000
-3,000
-23% -$104K ﹤0.01% 884
2016
Q1
$487K Hold
13,000
﹤0.01% 792
2015
Q4
$561K Hold
13,000
﹤0.01% 784
2015
Q3
$487K Hold
13,000
﹤0.01% 791
2015
Q2
$442K Hold
13,000
﹤0.01% 775
2015
Q1
$460K Buy
+13,000
New +$465K ﹤0.01% 809

Other funds holding MYGN